WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the release of Special Counsel Robert Mueller’s report:
WASHINGTON, D.C. – A trio of senior U.S. lawmakers, including Rep.
DENVER, CO – U.S. Rep. Diana DeGette (D-CO) said today it’s “unacceptable” that the future state of Colorado’s economy lies in the hands of one person.
WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare.
WASHINGTON, D.C. – “The system is broken,” U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military’s policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.
WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today that would prevent the federal government from enforcing its prohibition on marijuana in states, such as Colorado, where it is legal for residents to possess and use the drug.
WASHINGTON, D.C. – A bipartisan group of lawmakers introduced legislation today seeking to bring down the cost of certain biologic drugs, such as insulin, by making it easier for drug makers to get generic versions of those drugs approved by the Food and Drug Administration.